guanabenz and Parkinson Disease

guanabenz has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aimé, P; Burke, RE; Crary, JF; Dai, D; Greene, LA; Levy, OA; Ramalingam, N; Sun, X	1

Other Studies

1 other study(ies) available for guanabenz and Parkinson Disease

Article	Year
Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease. Experimental neurology, 2018, Volume: 303 Topics: Activating Transcription Factor 4; Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cell Death; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Guanabenz; Humans; Mesencephalon; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphorylation; Protein Phosphatase 1; Rats; Ubiquitin-Protein Ligases; Up-Regulation	2018

Article

Year

Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.

Experimental neurology, 2018, Volume: 303

Topics: Activating Transcription Factor 4; Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cell Death; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Guanabenz; Humans; Mesencephalon; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphorylation; Protein Phosphatase 1; Rats; Ubiquitin-Protein Ligases; Up-Regulation

2018